Atlas Trials

Safety and Efficacy of Intranasal Administration of Niclosamide (UNI91103) in Adults With Asymptomatic or Mild COVID-19

Clinical trial NCT04932915 · TERMINATED

Trial details

NCT number
NCT04932915
Sponsor
UNION therapeutics
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Covid19
Start date
2021-09-03
Primary completion
2022-01-10
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.